The most interesting distinguishing characteristic of antibodies is their uniqueness; they are made to attach only to the antigen, a specific portion of the pathogen . Binding sites can be identified using molecular docking, an advanced technique in computational biology . Antibodies can be designed to attach to these sites precisely . The antibodies designed can block the harmful function of the protein due to their precision . Using information from molecular docking, monoclonal antibodies are created to neutralize particular proteins in diseases such as cancer, autoimmune disorders, and pathogenic bacteria . Engineering antibodies using computational biology that target life-threatening proteins has revolutionized current therapeutics, revitalizing the development of highly effective biological medicine .